Login

BIOTECHNOLOGY VALUE FUND L P 4 SEC Filings

Filed On Filing
18 Sep 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · Immunic, Inc.

Granted 25,370 Stock Option

16 Jul 2026 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · XOMA Royalty Corp

Disposed of 7,593,303 shares (Tender Offer)

26 Jun 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · Kymera Therapeutics, Inc.

Sold 1,630,658 shares ($174M)

25 Jun 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · Kymera Therapeutics, Inc.

Granted 6,068 Stock Option (Right to Buy)

23 Jun 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · Olema Pharmaceuticals, Inc.

Granted 29,500 Stock Option (Right to buy)

22 Jun 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · MoonLake Immunotherapeutics

Granted 22,195 Option to Buy

18 May 2026 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · XOMA Royalty Corp

Received 5,003,000 shares by conversion ($20.2M)

02 Apr 2026 Form 4: Bvf Partners L P/IL, Director and 9 others · MoonLake Immunotherapeutics

Sold 3,750,000 shares ($63M)

30 Jan 2026 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · Repare Therapeutics Inc.

Disposed of 10,166,943 shares (Tender Offer)

14 Oct 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · ESSA Pharma Inc.

Disposed of 11,481,685 shares (Tender Offer)

07 Aug 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · ESSA Pharma Inc.

Received 2,920,000 shares by exercise ($292) · Sold 156 shares ($293)

01 Jul 2025 Form 4: Bvf Partners L P/IL, Director and 9 others · Kymera Therapeutics, Inc.

Granted 16,000 Stock Option (Right to Buy) · Bought 317,167 shares ($14M)

17 Jun 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · Crescent Biopharma, Inc.

Acquired 1,270,004 shares (Other Transaction) · Acquired 587,557 Pre-Funded Warrants to Purchase Common Stock (Other Transaction)

13 Jun 2025 Form 4: Bvf Partners L P/IL, Director and 9 others · Olema Pharmaceuticals, Inc.

Granted 24,150 Stock Option (Right to buy)

09 Jun 2025 Form 4: Bvf Partners L P/IL, Director and 9 others · MoonLake Immunotherapeutics

Granted 6,682 Option to Buy

20 May 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · XOMA Royalty Corp

Sold 392,723 shares ($10.6M)

19 May 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · Allakos Inc.

Returned 16,312,872 shares to the issuer

28 Jan 2025 Form 4: Bvf Partners L P/IL, 10% owner and 9 others · XOMA Royalty Corp

Sold 650,717 shares ($17M)

14 Jan 2025 Form 4: Bvf Partners L P/IL, Director and 9 others · Olema Pharmaceuticals, Inc.

Returned 420,000 shares to the issuer · Granted 420,000 Pre-Funded Warrant

17 Dec 2024 Form 4: Bvf Partners L P/IL, See Explanation of Responses and 9 others · Palvella Therapeutics Inc

Acquired 438,929 shares (Other Transaction)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support